---
title: "BEN-JOSEF EDGAR — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ba09773e-d155-5374-aeb7-da938ea13ce8
json: https://whiteintel.dev/api/public/dossier/ba09773e-d155-5374-aeb7-da938ea13ce8
identifier: sec:0001302402
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BEN-JOSEF EDGAR

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001302402`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ba09773e-d155-5374-aeb7-da938ea13ce8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ba09773e-d155-5374-aeb7-da938ea13ce8  

## Ownership & control

### Holdings / subsidiaries

- **GALECTIN THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/f8080f77-4e50-5fe6-9c7b-cf0486465d72

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BEN-JOSEF EDGAR**. Human view: https://whiteintel.dev/entity/ba09773e-d155-5374-aeb7-da938ea13ce8 · Structured JSON: https://whiteintel.dev/api/public/dossier/ba09773e-d155-5374-aeb7-da938ea13ce8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._